Arcutis Biotherapeutics, Inc. ARQT

Latest FY: 2025 Healthcare Biotechnology
Market Price $23.66
Market Cap $2.96B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑91.3% YoY
$376.07M
3-Yr CAGR: 367.3%
Net Income ↑88.5% YoY
-$16.14M
Net Margin: -4.3%
Free Cash Flow ↑94.4% YoY
-$6.31M
FCF Yield: -0.21%
EPS (Diluted) ↑88.8% YoY
$-0.13
Basic: $-0.13
Return on Equity Efficiency
-8.5%
ROA: -3.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ARQT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017
FY 2018 $-19.3M $-14.1M $-14.1M
FY 2019 $-36.5M $-42.0M -118.1% $-42.8M $-43.1M -206.2%
FY 2020 $-135.7M -223.1% 0.00% $-113.0M $-113.4M -162.8%
FY 2021 $-206.4M -52.1% $-4.18 0.00% $-174.6M $-175.6M -54.9%
FY 2022 $3.7M $2.9M $-311.5M -50.9% $-5.66 -35.4% 0.00% $-257.7M $-258.0M -46.9%
FY 2023 $59.6M +1,517.1% $29.9M $-262.1M +15.8% $-3.78 +33.2% 0.00% $-247.1M $-247.5M +4.1%
FY 2024 $196.5M +229.7% $169.4M $-140.0M +46.6% $-1.16 +69.3% 0.00% $-112.2M $-112.3M +54.6%
FY 2025 $376.1M +91.3% $339.4M $-16.1M +88.5% $-0.13 +88.8% 0.00% $-5.6M $-6.3M +94.4%
$

Valuation

Market Price $23.66
Market Cap $2.96B
Enterprise Value $3.03B
P/E Ratio N/A
P/B Ratio 15.62
FCF Yield -0.21%
Dividend Yield N/A
Shares Outstanding 125,083,400
%

Profitability & Margins

Gross Margin 90.24%
Operating Margin -3.25%
Net Margin -4.29%
Return on Equity (ROE) -8.52%
Return on Assets (ROA) -3.73%
Asset Turnover 0.87x
Revenue 3-Yr CAGR 367.27%
🛡️

Financial Health & Liquidity

Current Ratio 3.17
Cash Ratio 0.33
Debt / Equity 0.575
Debt / Assets 0.252
Cash & Equivalents $42.91M
Total Debt $108.96M
Book Value / Share $1.51
💧

Cash Flow Efficiency

Operating Cash Flow -$5.62M
Capital Expenditures (CapEx) $686.00K
Free Cash Flow -$6.31M
OCF / Revenue -1.50%
FCF / Revenue -1.68%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.13
EPS (Basic) $-0.13
Dividends / Share N/A
Book Value / Share $1.51
EPS YoY Growth 88.79%
🏛️

Balance Sheet (FY 2025)

Total Assets $432.97M
Total Liabilities $243.49M
Stockholders' Equity $189.48M
Current Assets $411.23M
Current Liabilities $129.84M